$STX

MOSLEY WILLIAM D sold $2.3M of STX

MOSLEY WILLIAM D (CEO) sold 2,855 shares of Seagate Technology Holdings plc (STX) at an average of $821.74 ($821.74–$821.75, $2.35M total) across 2 trades on 2026-06-10.

Original reporting
SEC EDGAR · MOSLEY WILLIAM D
Published Jun 11, 2026, 8:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$STX
Neutral
medium confidence
Mentioned
$STX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$STXNeutralLow
01

Why it matters

The only new fact is the CEO’s open-market sale size, price range, and post-transaction holdings; it does not include any operational or financial updates.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a sustained repricing without accompanying company fundamentals.

03

What to watch

Insider sales can be driven by diversification, tax planning, or pre-existing personal liquidity needs; without additional filings or patterns, the signal may be overstated.

Relevance 6/10Novelty 6/10Timing: Filed June 11; sale executed June 10.

Background

The article is an SEC Form 4 insider transaction disclosure for Seagate Technology Holdings plc.

Company-level read

Ticker impact

$STXNeutralMedium confidence
Context

Seagate CEO William D. Mosley sold $2.35M of STX shares in an open-market transaction disclosed via SEC Form 4 on June 10.

Expected impact

Likely limited near-term impact; any reaction should be small and fade unless follow-on selling or other fundamentals emerge.

Evidence & confidence

The filing is a primary-source insider transaction, but it provides no new business/financial information and the article lacks context on motives beyond the sale details.

Market effects

Minimal—single-company insider sale does not reset sector fundamentals.

Minimal—no regional macro or cross-border transaction details.

Minimal—no global supply chain, litigation, or deal implications described.

Counterpoint

Because the CEO sold without a disclosed pre-arranged 10b5-1 plan, some traders may interpret it as a stronger negative signal than typical routine sales.

Key entities

  • Seagate Technology Holdings plc

    Subject of the SEC Form 4 insider sale by its CEO.

  • MOSLEY WILLIAM D

    CEO and officer/director who sold STX shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAHighAI 9/10

Markets News, Aug. 27, 2026: Nvidia Stock Powers Higher After Earnings, Driving Tech Gains; Nasdaq Closes Sharply Higher

Nvidia (NVDA) reported strong Q2 earnings and raised Q3 revenue guidance to $108B, driving its stock up 9% and boosting tech sector gains. Nasdaq, S&P 500, and Dow closed higher. Other notable movers include Okta (OKTA) +29%, Salesforce (CRM) +23%, and CrowdStrike (CRWD) +20%. Corporate profits surged $400B in Q2, partly due to $71B in tariff refunds.

$STXMed

Moody’s upgrades Seagate Data rating on AI demand strength

Moody's upgraded Seagate Data's corporate family rating to Ba1 from Ba2, citing AI-driven demand for high-capacity HDDs. The agency expects revenues to grow over 30% annually, reaching $20B, and debt to EBITDA to fall below 0.5x. Seagate faces risks from revenue concentration and pricing pressures. The company had $1.7B in cash and access to a $1.3B credit facility as of July 2026.

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

$STXMed

REG - Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US

Shield Therapeutics (STX) will take full control of ACCRUFeR® in the US from Viatris by September 30, 2026. The deal is expected to boost Shield's profitability and growth, with no upfront payments to Viatris. Shield will pay royalties on US net sales, ranging from high single digits to mid-teens over five years, and retain all gross profits from US sales. The transaction is anticipated to enhance Shield's financial profile and support its path to sustained profitability.